{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:44:20Z","timestamp":1760060660499,"version":"build-2065373602"},"reference-count":26,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Slovenian Research and Innovation Agency P3-0457 research program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCDD"],"abstract":"<jats:p>Background: Beyond its established inotropic effects, levosimendan has been reported to enhance renal function in patients with chronic heart failure. In this study, we investigated whether changes in renal function following levosimendan administration in patients listed for heart transplantation were associated with early post-transplant renal outcomes. Methods: We retrospectively analyzed data from 99 patients with advanced heart failure and renal insufficiency (eGFR &lt; 90 mL\/min\/1.73 m2) who were listed for heart transplantation and received levosimendan therapy within 1 to 6 months prior to transplantation. Renal function was assessed immediately before and 24 h after levosimendan administration. A favorable renal response was defined as any increase in eGFR at 24 h. Post-transplant renal function was evaluated on postoperative days 1 and 7 using standard renal function parameters. Results: Favorable renal response to levosimendan prior to heart transplantation was present in 73 of 99 patients (74%, Group A), and 26 patients (26%) displayed no increase in eGFR (Group B). In the first week after heart transplantation, we found a significant improvement in renal function in Group A (\u0394eGFR: +14 \u00b1 3 mL\/min\/1.73 m2, p &lt; 0.001), and worsening of renal function in Group B (\u0394eGFR: \u22124 \u00b1 3 mL\/min\/1.73 m2, p &lt; 0.01). Favorable response to levosimendan prior to heart transplantation was an independent correlate of improved renal function after heart transplantation (p = 0.01). Conclusion: In patients awaiting heart transplantation, improvement in renal function after levosimendan therapy was associated with better early post-transplant renal outcomes. Levosimendan response may thus help identify reversible renal dysfunction and serve as a simple tool for transplant evaluation.<\/jats:p>","DOI":"10.3390\/jcdd12090357","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T10:06:25Z","timestamp":1758017185000},"page":"357","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Renal Response to Levosimendan in Advanced Chronic Heart Failure Patients Listed for Heart Transplantation Predicts Early Postoperative Renal Function Course"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6082-5176","authenticated-orcid":false,"given":"Gregor","family":"Zemljic","sequence":"first","affiliation":[{"name":"Advanced Heart Failure and Transplantation Center, Department of Cardiology, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1777-8807","authenticated-orcid":false,"given":"Gregor","family":"Poglajen","sequence":"additional","affiliation":[{"name":"Advanced Heart Failure and Transplantation Center, Department of Cardiology, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia"},{"name":"Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3691-4982","authenticated-orcid":false,"given":"Sabina","family":"Frljak","sequence":"additional","affiliation":[{"name":"Advanced Heart Failure and Transplantation Center, Department of Cardiology, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8881-2251","authenticated-orcid":false,"given":"Andraz","family":"Cerar","sequence":"additional","affiliation":[{"name":"Advanced Heart Failure and Transplantation Center, Department of Cardiology, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Okrajsek","sequence":"additional","affiliation":[{"name":"Advanced Heart Failure and Transplantation Center, Department of Cardiology, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9907-3522","authenticated-orcid":false,"given":"Miran","family":"Sebestjen","sequence":"additional","affiliation":[{"name":"Advanced Heart Failure and Transplantation Center, Department of Cardiology, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia"},{"name":"Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9151-6587","authenticated-orcid":false,"given":"Ivan","family":"Knezevic","sequence":"additional","affiliation":[{"name":"Advanced Heart Failure and Transplantation Center, Department of Cardiology, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bojan","family":"Vrtovec","sequence":"additional","affiliation":[{"name":"Advanced Heart Failure and Transplantation Center, Department of Cardiology, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia"},{"name":"Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/TP.0000000000000151","article-title":"Risk stratification for in-hospital mortality after heart transplantation using the modification of diet in renal disease and the chronic kidney disease epidemiology collaboration equations for estimated glomerular filtration rate","volume":"98","author":"Singh","year":"2014","journal-title":"Transplantation"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ","volume":"349","author":"Ojo","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1097\/TP.0000000000003159","article-title":"Estimated Glomerular Filtration Rate at Transplant Listing and Other Predictors of Post-Heart Transplant Mortality and the Development of ESRD","volume":"104","author":"Kumar","year":"2020","journal-title":"Transplantation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/00007890-199703150-00009","article-title":"Cyclosporine-associated end-stage nephropathy after cardiac transplantation: Incidence and progression","volume":"63","author":"Goldstein","year":"1997","journal-title":"Transplantation"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S1053-2498(01)00411-9","article-title":"The incidence of end-stage renal failure in 17 years of heart transplantation: A single center experience","volume":"21","author":"Satchithananda","year":"2002","journal-title":"J. Heart Lung Transplant."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.healun.2021.11.017","article-title":"Incidence and long-term outcome of heart transplantation patients who develop postoperative renal failure requiring dialysis","volume":"41","author":"Shoji","year":"2022","journal-title":"J. Heart Lung Transplant."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"576","DOI":"10.12659\/AOT.893788","article-title":"Risk Factors for Chronic Renal Insufficiency Following Cardiac Transplantation","volume":"20","author":"Lachance","year":"2015","journal-title":"Ann. Transplant."},{"key":"ref_8","unstructured":"National Kidney Foundation (NKF) Kidney Disease Outcome Quality Initiative (K\/DOQI) Advisory Board (2002). K\/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification: Kidney Disease Outcome Quality Initiative. Am. J. Kidney Dis., 39, S1\u2013S246."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"133281","DOI":"10.1016\/j.ijcard.2025.133281","article-title":"Inflammation in chronic heart failure: An unsolved puzzle","volume":"432","author":"Trimarchi","year":"2025","journal-title":"Int. J. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"132585","DOI":"10.1016\/j.ijcard.2024.132585","article-title":"An in-depth look at electrolytes in acute heart failure: The role of sodium-to-chloride ratio","volume":"417","author":"Trimarchi","year":"2024","journal-title":"Int. J. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cardfail.2007.03.005","article-title":"Levosimendan improves renal function in patients with advanced chronic heart failure awaiting cardiac transplantation","volume":"13","author":"Zemljic","year":"2007","journal-title":"J. Card. Fail."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/ctr.12424","article-title":"The effects of levosimendan on renal function early after heart transplantation: Results from a pilot randomized trial","volume":"28","author":"Knezevic","year":"2014","journal-title":"Clin. Transplant."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.healun.2005.07.011","article-title":"Peri-operative renal function and outcome after orthotopic heart transplantation","volume":"25","author":"Odim","year":"2006","journal-title":"J. Heart Lung Transplant."},{"key":"ref_15","first-page":"1355","article-title":"Implications of acute kidney injury after heart transplantation: What a surgeon should know","volume":"40","author":"Romano","year":"2011","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1600-6143.2008.02490.x","article-title":"The clinical impact of an early decline in kidney function in patients following heart transplantation","volume":"9","author":"Cantarovich","year":"2009","journal-title":"Am. J. Transplant."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.healun.2010.08.007","article-title":"The registry of the International Society for Heart and Lung Transplantation: Twenty-seventh official adult heart transplant report\u20132010","volume":"29","author":"Stehlik","year":"2010","journal-title":"J. Heart Lung Transplant."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1681\/ASN.V115951","article-title":"Predictors and evolution of renal function during 9 years following heart transplantation","volume":"11","author":"Bergh","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0140-6736(02)09455-2","article-title":"Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): A randomised double-blind trial","volume":"360","author":"Follath","year":"2002","journal-title":"Lancet"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejheart.2005.12.003","article-title":"Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE","volume":"8","author":"Cleland","year":"2006","journal-title":"Eur. J. Heart Fail."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1124\/jpet.112.193961","article-title":"Levosimendan protection against kidney ischemia\/reperfusion injuries in anesthetized pigs","volume":"342","author":"Grossini","year":"2012","journal-title":"J. Pharm. Exp. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.amjcard.2006.01.068","article-title":"Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure","volume":"98","author":"Adamopoulos","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10557-013-6485-6","article-title":"Renal effects of levosimendan: A consensus report","volume":"27","author":"Yilmaz","year":"2013","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Liu, X., Lu, M., Yu, Y., Shen, N., Xia, H., Shi, J., Fu, Y., and Hu, Y. (2024). Levosimendan: A new therapeutical strategy in patients with renal insufficiency. Cardiovasc. Drugs Ther., 1\u20138.","DOI":"10.1007\/s10557-024-07614-9"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1097\/CCM.0b013e31828e946a","article-title":"Effects of levosimendan on glomerular filtration rate, renal blood flow, and renal oxygenation after cardiac surgery with cardio-pulmonary bypass: A randomized placebo-controlled study","volume":"41","author":"Bragadottir","year":"2013","journal-title":"Crit. Care Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s13054-021-03628-z","article-title":"Effects of levosimendan on renal blood flow and glomerular filtration in patients with acute kidney injury after cardiac surgery: A double blind, randomized placebo-controlled study","volume":"25","author":"Ricksten","year":"2021","journal-title":"Crit. Care"}],"container-title":["Journal of Cardiovascular Development and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2308-3425\/12\/9\/357\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:46:16Z","timestamp":1760035576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2308-3425\/12\/9\/357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,16]]},"references-count":26,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["jcdd12090357"],"URL":"https:\/\/doi.org\/10.3390\/jcdd12090357","relation":{},"ISSN":["2308-3425"],"issn-type":[{"type":"electronic","value":"2308-3425"}],"subject":[],"published":{"date-parts":[[2025,9,16]]}}}